1. Home
  2. Companies
  3. OSX
  4. Material Events

Osteopore (ASX:OSX) — Material Events

ASX:OSX · 22 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Significant 13 articles Notable 9 articles Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
13
Osteopore Reports 10% Quarterly Revenue Growth, Expands Asia Pacific PartnershipsMedium
Osteopore reports 10% QoQ revenue growth, expands Asia Pacific partnerships and product innovations in Q1 CY26
30 Apr 2026 ·Quarterly Report ·85
Osteopore Launches OsteoRx with AUD 0.5m to Pioneer Cellular RegenerationMedium
Osteopore launches OsteoRx SPV with AUD 0.5m investment to expand regenerative medicine footprint
1 Sept 2025 ·Strategic Investment Announcement ·85
Osteopore Expands into China with Exclusive RMB 12m DealMedium
Osteopore secures exclusive RMB 12m distribution deal with Majeton for China market expansion
16 Jan 2026 ·Commercial Agreement Announcement ·85
Osteopore and DKSH Forge 5-Year Deal to Transform Malaysia’s Dental Regeneration MarketMedium
Osteopore inks 5-year deal with DKSH Malaysia to expand dental product distribution
25 Nov 2025 ·Commercial Partnership Announcement ·80
Osteopore Accelerates Growth with Swiss Approval and Expanding Global SalesMedium
Osteopore posts 7% YoY revenue growth, gains Swiss market approval, expands sales via Zimmer Biomet partnership, and wins Vietnam hospital tenders
31 Oct 2025 ·Quarterly Report ·80
Osteopore Secures Exclusive Deal to Enter China’s Lucrative Implant MarketMedium
Osteopore inks exclusive deal with Majeton for Chinese market access
16 Jan 2026 ·Commercial Collaboration Agreement ·80
Osteopore Targets Hong Kong Orthopaedic Market with Exclusive MontsMed DealMedium
Osteopore expands orthopaedic business into Hong Kong via exclusive MontsMed deal
22 Jan 2026 ·Market Expansion Announcement ·75
Osteopore Gains Strategic Hainan Approval for Orthopaedic Devices with First Surgery SetMedium
Osteopore secures Hainan FDA approval for custom orthopaedic devices with first surgery scheduled June 2026
26 May 2026 ·Regulatory Approval ·75
Osteopore Secures Middle East Deal to Grow Orthopaedic Market FootprintMedium
Osteopore expands orthopaedic product distribution into Middle East via 3-year deal with Al-Umnia
6 Aug 2026 ·Major Contract Announcement ·75
Osteopore Expands SEA Reach with Injectable Bone Filler Distribution DealMedium
Osteopore secures SEA distribution rights for injectable bone filler, expanding orthopaedic portfolio
12 Mar 2026 ·Distribution Agreement Announcement ·75
Osteopore Secures Singapore Rights for Game-Changing Dental Graft TechMedium
Osteopore secures Singapore distribution rights for autologous dentin graft technology, targeting ASEAN/APAC expansion
3 Mar 2026 ·ASX Announcement ·75
Osteopore Grows Revenue 30% Despite Regional Challenges, Seals DKSH DealMedium
Osteopore posts 30% revenue growth in Q4 CY25 and inks 5-year DKSH Malaysia dental partnership
30 Jan 2026 ·Quarterly Report ·75
Osteopore Expands Latin America Reach with Medprin PartnershipMedium
Osteopore inks exclusive Latin America craniofacial distribution deal with Medprin
13 Feb 2026 ·Partnership Announcement ·75
Notable Score 50–74
9
Osteopore Reports 8% Revenue Decline Amid Global Expansion EffortsMedium
Osteopore reports 8% revenue decline, 14% higher loss, expands global partnerships
31 Aug 2026 ·Half-Year Financial Report ·70
Osteopore Grows Revenue 11% Amid Rising Losses and Expansion in SingaporeMedium
Osteopore posts 11% revenue growth but wider net loss of $3.72M for 2025, expands Singapore subsidiary
27 Feb 2026 ·Appendix 4E Preliminary Final Report ·70
Osteopore Taps Hong Kong Gateway to Expand Orthopaedic ReachMedium
Osteopore expands orthopaedic business into Hong Kong via exclusive MontsMed agreement
22 Jan 2026 ·ASX Announcement ·70
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.